健麾信息拟7371万元收购AI应用公司博科国信38%股权

Group 1 - The company, Jianhui Information Technology Co., Ltd., plans to acquire 70% of the equity in Boke Guoxin (Wuhan) Technology Co., Ltd. through a series of transactions totaling approximately RMB 10,371.02 million [1][3] - The acquisition involves purchasing shares from four entities: Zhou Xiaoping (16.75%), Zepo Investment (13.25%), Boke Yixin (4.00%), and Boke Guoxin (4.00%) [3][4] - The target company is a member of the China Healthcare Information Interconnection Technology Alliance and has passed 13 system tests in the FHIR Connectathon, marking it as a leading healthcare IT enterprise in Central China [1][3] Group 2 - The acquisition is expected to enhance the company's core business by injecting innovative capabilities in medical AI applications, such as the B-Klinik intelligent agent, and will help expand opportunities in smart hospitals and community healthcare [1][3] - The transaction has been approved by the company's board of directors and does not require shareholder meeting approval as it does not constitute a related party transaction or a major asset restructuring [4][5]